Published in Science on June 02, 1972
Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35
H-2-linked immune response (Ir) genes. Independent loci for Ir-IgG and Ir-IgA genes. J Exp Med (1972) 2.50
Membrane molecules determined by the H-2 associated immune response region: isolation and some properties. Proc Natl Acad Sci U S A (1974) 2.17
Serologic evidence for antigens controlled by the Ir region in mice. J Exp Med (1973) 1.94
Graft-versus-host reactions across different regions of the H-2 complex of the mouse. J Exp Med (1973) 1.87
Specific binding of K- and I-region products of the H-2 complex to activated thymus-derived (T) cells belonging to different Ly subclasses. J Exp Med (1976) 1.42
Regulation of autosensitization. The immune activation and specific inhibition of self-recognizing thymus-derived lymphocytes. J Exp Med (1973) 1.20
The role of gene products of the I-J subregion in mixed lymphocyte reactions. J Exp Med (1977) 1.12
Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci. J Exp Med (1976) 1.11
Histocompatibility antigens controlled by the I region of the murine H-2 complex. II. K/D region compatibility is not required for I-region cell-mediated lymphocytotoxicity. J Exp Med (1977) 1.08
Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity. J Exp Med (1975) 1.04
Mapping of the immune response genes in the major histocompatibility complex of the Rhesus monkey. J Exp Med (1975) 1.02
Murine t factors: an association between alleles at t and at H-2. J Exp Med (1976) 1.01
Genetic analysis of patients with chronic active hepatitis. J Clin Invest (1975) 0.97
A new lymphocyte-activating determinant locus expressed on T cells, and mapping in I-C subregion. J Exp Med (1978) 0.88
Histocompatibility antigens in a genetically isolated American indian tribe. Am J Hum Genet (1973) 0.80
Genetic aspects of canine mixed leukocyte cultures. J Exp Med (1974) 0.79
Alloantiserum-induced inhibition of immune response gene product function. I. Cellular distribution of target antigens. J Exp Med (1974) 0.79
Responsiveness of germfree mice in mixed leukocyte culture. Reexamining the nature of the responding unit. J Exp Med (1972) 0.78
Genetic control of histocompatibility antigens. Am J Hum Genet (1973) 0.75
H-2 mutation affecting immune response to Thy-1.1 antigen. J Exp Med (1977) 0.75
Surface receptors on lymphoreticular cells: sensory devices for host recognition of foreign antigens and neoplasia. Can Med Assoc J (1980) 0.75
On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J Exp Med (1978) 9.51
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med (1997) 8.65
Evidence for transcriptional regulation of orotidine-5'-phosphate decarboxylase in yeast by hybridization of mRNA to the yeast structural gene cloned in Escherichia coli. Proc Natl Acad Sci U S A (1979) 6.81
One-way stimulation in mixed leukocyte cultures. Science (1966) 6.62
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32
Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest (2001) 5.94
Histocompatibility matching. VI. Miniaturization of the mixed leukocyte culture test: a preliminary report. Transplantation (1971) 5.43
The major histocompatibility complex of the mouse. Science (1979) 4.76
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A (1980) 4.35
Divergence time and population size in the lineage leading to modern humans. Theor Popul Biol (1995) 4.31
The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27
Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med (1972) 3.96
Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature (1976) 3.87
The H-2 model for the major histocompatibility systems. Transplant Rev (1971) 3.82
List of congenic lines of mice. I. Lines with differences at alloantigen loci. Transplantation (1973) 3.73
Bracteomania, an inflorescence anomaly, is caused by the loss of function of the MADS-box gene squamosa in Antirrhinum majus. EMBO J (1992) 3.60
cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science (1988) 3.56
Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med (2000) 3.41
The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment. Transplant Proc (1973) 3.35
Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. Cell Immunol (1972) 3.35
Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34
Serological identification of an Ir-region product. Science (1973) 3.32
Hu-1: Major histocompatibility locus in man. Science (1967) 3.13
The traditional and a new version of the mouse H-2 complex. Nature (1981) 3.12
Methodological concerns and recommendations on policy consequences of the World Health Report 2000. Lancet (2001) 3.04
Cell mediated immunity: separation of cells involved in recognitive and destructive phases. Science (1973) 3.04
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol (1993) 3.03
Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med (1968) 3.00
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (2001) 2.79
Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 2.79
Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J (1993) 2.75
MHC polymorphism pre-dating speciation. Nature (1988) 2.70
Therapy for acute otitis media. Preference of parents for oral or parenteral antibiotic. Arch Pediatr Adolesc Med (1996) 2.68
H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics (1983) 2.62
Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr (1988) 2.62
Detection of a novel human class II HLA antigen. Nature (1983) 2.61
Origin of major histocompatibility complex polymorphism: the trans-species hypothesis. Hum Immunol (1987) 2.51
Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature (1978) 2.51
The polymer mat: arrested rebound of a compressed polymer layer. Eur Phys J E Soft Matter (2002) 2.43
Phylogeny of Darwin's finches as revealed by mtDNA sequences. Proc Natl Acad Sci U S A (1999) 2.42
Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
Polymorphism and balancing selection at major histocompatibility complex loci. Genetics (1992) 2.34
Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev (1980) 2.32
Directly measured second hand smoke exposure and asthma health outcomes. Thorax (2005) 2.32
Molecular characterisation of the Arabidopsis SBP-box genes. Gene (1999) 2.31
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
Direct selective techniques for the isolation of pyrimidine auxotrophs in yeast. Mol Gen Genet (1972) 2.28
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem (1996) 2.26
Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. J Exp Med (1978) 2.24
Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol (2001) 2.19
Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA (1994) 2.18
Evolution of the major histocompatibility complex. Crit Rev Immunol (1986) 2.16
DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med (1991) 2.14
Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol (2001) 2.14
Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med (1990) 2.12
Degradation of phenanthrene, fluorene and fluoranthene by pure bacterial cultures. Appl Microbiol Biotechnol (1990) 2.12
Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol (1989) 2.11
H-2 mutations: their genetics and effect on immune functions. Adv Immunol (1978) 2.11
Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol (1993) 2.02
Role of H-2 lymphocyte-defined and serologically-defined components in the generation of cytotoxic lymphocytes. J Exp Med (1974) 2.01
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Nucleotide sequences of chimpanzee MHC class I alleles: evidence for trans-species mode of evolution. EMBO J (1988) 1.98
A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media. J Immunol Methods (1973) 1.97
Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response. Cell Immunol (1970) 1.97
Serologic evidence for antigens controlled by the Ir region in mice. J Exp Med (1973) 1.94
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes. Science (1975) 1.91
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N Engl J Med (1990) 1.91
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
Graft-versus-host reactions across different regions of the H-2 complex of the mouse. J Exp Med (1973) 1.87
Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med (1990) 1.83
Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82
Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants. Nature (1985) 1.82
Fluidity of water confined to subnanometre films. Nature (2001) 1.80
Tissue distribution of I region-associated antigens in the mouse. J Immunol (1974) 1.76
Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature (1987) 1.75
Lymphocyte reactivity in vitro. II. Soluble reconstituting factor permitting response of purified lymphocyte. Cell Immunol (1970) 1.74
Production of anti-H-2 antibodies in thymectomized mice. Eur J Immunol (1974) 1.74
Antigen-driven helper cell-independent cloned cytolytic T lymphocytes. Nature (1981) 1.72
DNA archives and our nearest relative: the trichotomy problem revisited. Mol Phylogenet Evol (2000) 1.71
H-2 types of translocation stocks T(2;9)138Ca, T(9;13)-190Ca and an H-2 recombinant. Transplantation (1970) 1.71
Allogeneic and xenogeneic response in mixed leukocyte cultures. J Exp Med (1972) 1.70